CTRI/2021/08/035869
Not yet recruiting
未知
A Randomised Double-blind Study to Compare the Intubating Conditions of Cisatracurium and Rocuronium for Intubation
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Malankara Orthodox Syrian Church Medical College
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients undergoing surgeries requiring general anesthesia (procedures requiring general anesthesia for one hour or more).
- •ASA Status of I and II.
- •BMI between 20 \- 30 kg/m2\.
Exclusion Criteria
- •Patients with anticipated difficult intubation.
- •Chronic alcoholics.
- •Patients with diseases affecting neuromuscular transmission.
- •Patients on medications known to interfere with neuromuscular blockers.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Spinal anaesthesia with Levobupivacaine with dexmedetomidine and fentanyl for surgeries below naveus.Health Condition 1: K353- Acute appendicitis with localizedperitonitisHealth Condition 2: K402- Bilateral inguinal hernia, withoutobstruction or gangreneHealth Condition 3: O- Medical and SurgicalCTRI/2024/08/071981PACIFIC MEDICAL COLLEGE AND HOSPITAL UDAIPUR
Completed
Phase 4
A clinical trial to study the effects of two drugs, oral midazolam and intranasal dexmedetomidine as premedication in children.CTRI/2013/10/004066okamanya Tilak Muncipal Medical College and Hospital60
Not yet recruiting
Phase 3
Study of post operative sore throat, hoarseness of voice and cough after nebulization with ketamine and magnesium sulphate in patients undergoing general anaesthesia.Health Condition 1: O- Medical and SurgicalCTRI/2024/03/063567JLN Medical College
Active, not recruiting
Not Applicable
Randomized, double-blind, study to compare the incidence and intensity lf neurologic and pschiatic adverse events of efavirenz when given as a stepped dosage (200 mg qd for 6 days, 400 mg qd for 7 days and 600 mg qd from the day 14 farward) with the usual dosage (600 mg qd from first day)Pacientes infectados por el VIH a los que su medico responsable les haya prescrito efavirez como parte de su tratamiento antiretroviralMedDRA version: 6.0Classification code 10008919EUCTR2005-003243-31-ESuis Fernando López Cortés100
Completed
Not Applicable
Comparative study of various analgesic methods in Pediatric cardiac surgeryCTRI/2019/02/017575vrajesh kumar kodali